FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for rapid assessment of aspirin resistance. That is ensured by ultrasonic oscillations with frequency of 150–160 kHz for a whole blood sample in volume of 25 mcl, placed in a measuring chamber before taking aspirin and 4 hours after taking it. Thereafter, echocoagulogram is recorded and in time intervals: 0.3 minutes, 2 minutes, 3 minutes, 5 minutes determine amplitude values, curve inclination angle, integral index, sector area. That is followed by analyzing the results, and if observing the results of the study after taking aspirin by more than 50 %, the absence of aspirin resistance in the patient is stated.
EFFECT: invention enables determining aspirin resistance in a patient using microvolumes of capillary blood.
1 cl, 8 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE AND METHOD FOR EXPRESS ASSESSMENT OF FUNCTIONAL STATE OF HAEMOSTASIS SYSTEM | 2018 |
|
RU2693939C1 |
| APPARATUS AND METHOD FOR EXPRESS ESTIMATION OF AGGREGATIVE ACTIVITY OF FORMED ELEMENTS OF BLOOD | 2020 |
|
RU2750839C1 |
| METHOD FOR PRESCRIBING INDIVIDUAL ANTITHROMBOTIC THERAPY IN ACUTE AND EARLY PERIODS OF SPINOCRONOUS INJURY OF THE CERVICAL SPINE | 2021 |
|
RU2770633C1 |
| METHOD FOR PREDICTION OF INTRAOPERATIVE BLOOD LOSS IN PATIENTS WITH IDIOPATHIC SCOLIOSIS | 2016 |
|
RU2635503C1 |
| METHOD OF ESTIMATION OF AGGREGATION ACTIVITY OF THROMBOCYTES | 2016 |
|
RU2666945C2 |
| METHOD FOR PERFORMING LOW-FREQUENCY PIEZOTHROMBOELASTOGRAPHY IN SMALL LABORATORY ANIMALS | 2016 |
|
RU2634567C1 |
| METHOD FOR EVALUATION OF BLOOD PLATELET FUNCTION IN WHOLE CITRATED BLOOD | 2016 |
|
RU2659421C2 |
| METHOD FOR ESTIMATION OF INCREASED RISK OF PHLEBOTHROMBOSES FORMATION IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2016 |
|
RU2624859C1 |
| METHOD FOR DETERMINING AN ANTICOAGULANT POTENTIAL OF A VASCULAR WALL | 2018 |
|
RU2690856C1 |
| METHOD OF PREDICTION OF ASPIRIN RESISTANCE | 2015 |
|
RU2602664C1 |
